查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1830970

深奥的测试市场

Esoteric Testing Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

预计深度测试市场将从 2024 年的 344 亿美元扩大到 2031 年的 918.1 亿美元，预计 2025 年至 2031 年的复合年增长率为 15.1%。

市场洞察与分析师观点：特殊检测涉及分析各种样本中的稀有物质或分子，并非标准检测程序的一部分。这个诊断环节需要训练有素的专业人员和精密复杂的设备。此类检测主要在专门的实验室进行，样本要么由医疗服务提供者转介（住院检测），要么由患者自行提交（门诊检测）。其中一些检测采用放射免疫分析技术，该技术以成本高且耗时长而闻名。近年来，COVID-19 疫情显着推动了特殊检测市场的发展。 RT-PCR 检测被广泛用于定性检测疑似 COVID-19 患者呼吸道样本（透过鼻咽拭子或口咽拭子、痰液等采集）中的 SARS-CoV-2 RNA。

成长催化剂：慢性病发生率上升推动深奥检测市场

美国癌症协会于2022年1月发布的《2022年癌症事实与数据》报告显示，2022年美国新增癌症病例近190万例，癌症相关死亡人数达609,360人。美国心臟协会2021年的一项研究预测，到2035年，美国将有超过1.3亿成年人可能患有某种形式的心臟病。癌症和其他慢性病发生率的上升凸显了准确诊断和治疗的重要性。根据美国甲状腺协会的估计，预计超过12%的美国人口在其一生中会患有甲状腺疾病。由于不健康的饮食习惯和久坐不动的生活方式，激素紊乱的盛行率不断上升，导致北美内分泌科检测的数量增加。内分泌测试对于诊断荷尔蒙失调至关重要，包括与脑下垂体、甲状腺、肾上腺、骨骼、类癌、神经内分泌和副甲状腺肿瘤相关的荷尔蒙失调。

此外，慢性病发病率的上升以及针对特定治疗领域的专用检测试剂盒的推出，预计将在未来几年推动特殊检测市场的成长。世界卫生组织于2021年10月报告称，到2030年，全球每6人中就有1人年龄在60岁或以上。预计到2050年，60岁及以上人口将从2020年的10亿增加到14亿。随着老年人口更容易患上遗传疾病和慢性疾病，预计在预测期内，特殊检测的需求将大幅增加。

根据美国疾病管制与预防中心 (CDC) 的数据，2022 年 9 月报告了 420 例西尼罗河病毒病新病例，其中 65% 为神经侵袭性病例，35% 为非神经侵袭性病例。这些罕见疾病可以透过专门的传染病检测方法有效识别，从而进一步推动市场成长。

战略洞察

报告细分和范围：「深度检测市场」按类型、技术和最终用户进行分类。按类型划分，市场包括传染病检测、内分泌学检测、肿瘤学检测、毒理学检测、免疫学检测、神经病学检测等。依技术划分，深度检测市场分为化学发光免疫分析、酵素连结免疫吸附测定、质谱法、即时PCR、DNA定序、流式细胞仪等。依最终用户划分，市场分为医院和实验室，以及独立实验室和参考实验室。

細項分析：深层检测市场按类型细分为传染病检测、内分泌学检测、肿瘤学检测、毒理学检测、免疫学检测、神经学检测等。肿瘤学检测领域在2022年占据了最大的市场份额，而传染病检测领域预计在2022年至2030年期间的复合年增长率最高。

从技术面来看，深层检测市场分为化学发光免疫分析、酵素连结免疫吸附分析、质谱法、即时PCR、DNA定序、流式细胞仪等。化学发光免疫分析领域在2022年占据最大市场份额，而酵素连结免疫吸附分析领域预计在2022年至2030年期间达到18.7%的最高复合年增长率。

按最终用户划分，深度测试市场分为医院和实验室，以及独立实验室和参考实验室。医院和实验室在2022年占据了更大的市场份额，预计2022年至2030年期间的复合年增长率将达到15.2%。

区域分析：全球深层测试市场分为亚太地区、欧洲、中东和非洲、北美以及南美和中美。 2022年，北美占据最大市场份额，而预计2022年至2030年期间，亚太地区将在深层测试市场中实现最高的复合年增长率。

北美的深层检测市场进一步细分为美国、加拿大和墨西哥。美国市场主要受慢性病盛行率上升和人们对早期发现疾病意识增强的推动。深层检测通常用于分析标准检测中未涵盖的稀有和独特物质。临床实验室需要专业知识才能进行这些检测，因此大型商业实验室将复杂的检测外包给参考实验室和深层检测实验室。在美国，进行深层检测的知名实验室包括Quest Diagnostics Incorporated、Mayo Medical Laboratories、ARUP Laboratories、Myriad Genetics、Genomic Health、Foundation Medicine和Laboratory Corporation of America。在美国，能够进行这些专业检测的实验室数量正在增加。

美国内分泌学会2022年1月发表的文章指出，性腺功能低下是美国男性的普遍疾病，尤其在老年男性、肥胖男性以及2型糖尿病患者中更为普遍；据估计，45岁以上男性中有35%患有性腺功能低下，而2型糖尿病或肥胖症男性中有30%-50%患有性腺功能低下。此外，根据美国人口普查局的数据，65岁及以上男性的性腺功能低下发生率从2000年的约3500万增加到2020年的约5500万，预计到2050年将接近8700万。这种疾病盛行率的上升与美国老龄人口的成长有关。此外，Statista报告称，2020年美国有5,1642名成年人死于肝病，慢性肝病/肝硬化是当年美国第12大死因；酒精性肝硬化病例的增加是该疾病的重要危险因子。

因此，性腺功能低下、肝硬化和其他类似疾病的病例不断增加，推动了全球深奥测试市场的成长。

深奥测试市场报告范围行业发展和未来机会：深奥测试市场主要参与者的关键倡议包括：

2022年3月，沃特世公司推出了Xevo TQ Absolute系统，这是一款紧凑型桌上型串联质谱仪。这款高灵敏度质谱仪可定量分析负离子化合物，灵敏度比上一代产品高出15倍，同时体积缩小了45%，耗电量和耗气量降低了50%。

2021 年 2 月，Quest Diagnostics 与 Grail 合作进行 Galleri 多癌种血液检测，计画利用 Galleri 多重癌症早期检测血液检测提供静脉穿刺服务。

竞争格局和主要公司：深奥测试市场的知名公司包括 Georgia Esoteric & Molecular Laboratory LLC、Laboratory Corp of America Holdings、Quest Diagnostics Inc.、National Medical Services Inc.、OPKO Health Inc.、ARUP Laboratories Inc.、bioMONTR Labs、Athena Esoterix LLC、Stanford Hospital & Clinicsies Inc.这些公司专注于引进新技术、增强现有产品并扩大其地理影响力，以满足日益增长的全球消费者需求。

目录

第一章：简介

第 2 章：执行摘要

  • 关键见解
  • 市场吸引力分析

第三章：研究方法

第四章：深层测试市场格局

  • 概述
  • PEST分析
  • 生态系分析
    • 价值链中的供应商列表

第五章：深奥测试市场－关键市场动态

  • 关键市场驱动因素
  • 主要市场限制因素
  • 关键市场机会
  • 未来趋势
  • 驱动因素和限制因素的影响分析

第六章：深奥测试市场 - 全球市场分析

  • 深奥测试 - 全球市场概览
  • 深奥测试－全球市场及2030年预测

第七章：深奥测验市场-收入分析-按类型，2020-2030

  • 概述
  • 传染病检测
  • 内分泌学检查
  • 肿瘤学检测
  • 毒理学测试
  • 免疫学检测
  • 神经病学检查
  • 其他的

第 8 章：深层测试市场 - 收入分析 - 按技术，2020-2030 年

  • 概述
  • 实时PCR
  • 流式细胞仪
  • 质谱法
  • 酵素连结免疫吸附试验
  • DNA定序
  • 化学发光免疫分析法
  • 其他技术

第 9 章：深奥测试市场 - 收入分析 - 按最终用户，2020-2030 年

  • 概述
  • 医院实验室
  • 独立和参考实验室

第 10 章：深奥测验市场 - 收入分析，2020-2030 年 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 欧洲其他地区
  • 亚太
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 11 章：产业格局

  • 併购
  • 协议、合作、合资企业
  • 新产品发布
  • 扩张和其他策略发展

第 12 章：竞争格局

  • 关键参与者的热图分析
  • 公司定位与集中度

第 13 章：深奥测试市场 - 主要公司简介

  • Georgia Esoteric and Molecular Laboratory LLC
  • Laboratory Corp of America Holdings
  • Quest Diagnostics Inc
  • National Medical Services Inc
  • OPKO Health Inc
  • ARUP Laboratories Inc
  • bioMONTR Labs
  • Athena Esoterix LLC
  • Stanford Hospital and Clinics
  • Foundation Medicine Inc

第 14 章：附录

简介目录
Product Code: TIPHE100001382

The esoteric testing market is anticipated to expand from US$ 34.40 billion in 2024 to US$ 91.81 billion by 2031, reflecting a projected CAGR of 15.1% from 2025 to 2031.

Market Insights and Analyst Perspective:Esoteric testing involves analyzing various samples for rare substances or molecules and is not part of standard testing procedures. This diagnostic segment necessitates highly trained professionals and sophisticated, intricate equipment. Such tests are primarily conducted in specialized laboratories, where samples are either referred by healthcare providers (inpatient testing) or submitted by patients themselves (outpatient testing). Some of these tests utilize the radioimmunoassay technique, which is known for being both costly and time-intensive. The COVID-19 pandemic has significantly boosted the esoteric testing market in recent years. The RT-PCR test is widely used for the qualitative detection of SARS-CoV-2 RNA from respiratory samples (collected via nasopharyngeal or oropharyngeal swabs, sputum, etc.) from individuals suspected of having COVID-19.

Growth Catalysts:Increasing Incidence of Chronic Diseases Fuels Esoteric Testing Market

The "Cancer Facts and Figures 2022" report from the American Cancer Society, published in January 2022, indicates that the US saw nearly 1.9 million new cancer cases and 609,360 cancer-related deaths in 2022. A study by the American Heart Association in 2021 projected that over 130 million adults in the US could be affected by some form of heart disease by 2035. The rising rates of cancer and other chronic diseases underscore the necessity for accurate diagnoses and treatments. According to estimates from the American Thyroid Association, more than 12% of the US population is expected to develop a thyroid condition during their lifetime. The increasing prevalence of hormonal disorders, driven by unhealthy eating habits and sedentary lifestyles, has led to a rise in endocrinology testing in North America. Endocrine tests are essential for diagnosing hormonal disorders, including those related to the pituitary, thyroid, adrenal, bone, carcinoid, neuroendocrine, and parathyroid tumors.

Moreover, the growing incidence of chronic diseases and the launch of specialized testing kits for specific therapeutic areas are expected to propel the esoteric testing market's growth in the coming years. The WHO reported in October 2021 that by 2030, 1 in 6 people globally will be aged 60 or older. The population aged 60 and above is projected to increase from 1 billion in 2020 to 1.4 billion by 2050. As the elderly population becomes more vulnerable to genetic and chronic diseases, the demand for esoteric tests is anticipated to rise significantly during the forecast period.

According to the CDC, in September 2022, there were 420 new cases of West Nile virus disease reported, with 65% classified as neuroinvasive and 35% as non-neuroinvasive. These rare diseases can be effectively identified through esoteric tests for infectious diseases, further driving market growth.

Strategic Insights

Report Segmentation and Scope:The "esoteric testing market" is categorized by type, technology, and end user. By type, the market includes infectious disease testing, endocrinology testing, oncology testing, toxicology testing, immunology testing, neurology testing, and others. In terms of technology, the esoteric testing market is divided into chemiluminescence immunoassay, enzyme-linked immunosorbent assay, mass spectrometry, real-time PCR, DNA sequencing, flow cytometry, and others. For end users, the market is segmented into hospitals and laboratories, as well as independent and reference laboratories.

Segmental Analysis:The esoteric testing market is segmented by type into infectious disease testing, endocrinology testing, oncology testing, toxicology testing, immunology testing, neurology testing, and others. The oncology testing segment accounted for the largest market share in 2022, while the infectious disease testing segment is expected to exhibit the highest CAGR from 2022 to 2030.

In terms of technology, the esoteric testing market is divided into chemiluminescence immunoassay, enzyme-linked immunosorbent assay, mass spectrometry, real-time PCR, DNA sequencing, flow cytometry, and others. The chemiluminescence immunoassay segment held the largest market share in 2022, while the enzyme-linked immunosorbent assay segment is projected to achieve the highest CAGR of 18.7% from 2022 to 2030.

By end user, the esoteric testing market is categorized into hospitals and laboratories, and independent and reference laboratories. The hospitals and laboratories segment held a larger market share in 2022 and is expected to grow at a higher CAGR of 15.2% from 2022 to 2030.

Regional Analysis:The global esoteric testing market is divided into Asia Pacific, Europe, the Middle East & Africa, North America, and South & Central America. In 2022, North America held the largest market share, while Asia Pacific is projected to register the highest CAGR in the esoteric testing market from 2022 to 2030.

The esoteric testing market in North America is further divided into the US, Canada, and Mexico. The US market is primarily driven by the increasing prevalence of chronic diseases and heightened awareness regarding early detection of medical conditions. Esoteric tests are typically conducted to analyze rare and unique substances not included in standard tests. Clinical laboratories require specialized expertise to perform these tests, leading large commercial laboratories to outsource complex tests to reference and esoteric testing laboratories. Notable labs conducting esoteric testing in the US include Quest Diagnostics Incorporated, Mayo Medical Laboratories, ARUP Laboratories, Myriad Genetics, Genomic Health, Foundation Medicine, and Laboratory Corporation of America. The number of laboratories capable of performing these specialized tests is on the rise in the country.

An article published by the Endocrine Society in January 2022 noted that hypogonadism is a prevalent condition among males in the US, particularly among older and obese men, as well as those with type 2 diabetes; it is estimated that 35% of men over 45 and 30-50% of men with type 2 diabetes or obesity have hypogonadism. Furthermore, according to the US Census Bureau, the incidence of hypogonadism in men aged 65 and older increased from approximately 35 million in 2000 to around 55 million by 2020, with projections of nearly 87 million by 2050. The rising prevalence of this condition correlates with the growing elderly population in the US. Additionally, Statista reported that 51,642 adults in the US died from liver disease in 2020, with chronic liver disease/cirrhosis ranked as the 12th leading cause of death in the US that year; the increase in alcoholic cirrhosis cases is a significant risk factor for this disease.

Consequently, the rising cases of hypogonadism, hepatic cirrhosis, and other similar conditions are propelling the growth of the global esoteric testing market.

Esoteric Testing Market Report Scope Industry Developments and Future Opportunities:Key initiatives by major players in the esoteric testing market include:

In March 2022, Waters Corporation introduced the Xevo TQ Absolute system, a compact benchtop tandem mass spectrometer. This highly sensitive mass spectrometer quantifies negatively ionizing compounds with up to 15-fold greater sensitivity than its predecessor, while being 45% smaller and consuming up to 50% less electricity and gas.

In February 2021, Quest Diagnostics partnered with Grail for its Galleri multicancer blood tests, planning to offer phlebotomy services utilizing the Galleri multicancer early-detection blood tests.

Competitive Landscape and Key Companies:Prominent companies in the esoteric testing market include Georgia Esoteric & Molecular Laboratory LLC, Laboratory Corp of America Holdings, Quest Diagnostics Inc., National Medical Services Inc., OPKO Health Inc., ARUP Laboratories Inc., bioMONTR Labs, Athena Esoterix LLC, Stanford Hospital & Clinics, and Foundation Medicine Inc. These companies are focused on introducing new technologies, enhancing existing products, and expanding their geographic presence to meet the increasing global consumer demand.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Esoteric Testing Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Esoteric Testing Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Esoteric Testing Market - Global Market Analysis

  • 6.1 Esoteric Testing - Global Market Overview
  • 6.2 Esoteric Testing - Global Market and Forecast to 2030

7. Esoteric Testing Market - Revenue Analysis (USD Million) - By Type, 2020-2030

  • 7.1 Overview
  • 7.2 Infectious Disease Testing
  • 7.3 Endocrinology Testing
  • 7.4 Oncology Testing
  • 7.5 Toxicology Testing
  • 7.6 Immunology Testing
  • 7.7 Neurology Testing
  • 7.8 Others

8. Esoteric Testing Market - Revenue Analysis (USD Million) - By Technology, 2020-2030

  • 8.1 Overview
  • 8.2 Real-Time PCR
  • 8.3 Flow Cytometry
  • 8.4 Mass Spectrometry
  • 8.5 Enzyme-Linked Immunosorbent Assay
  • 8.6 DNA Sequencing
  • 8.7 Chemiluminescence Immunoassay
  • 8.8 Other Technologies

9. Esoteric Testing Market - Revenue Analysis (USD Million) - By End User, 2020-2030

  • 9.1 Overview
  • 9.2 Hospital Laboratories
  • 9.3 Independent and Reference Laboratories

10. Esoteric Testing Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

  • 10.1 North America
    • 10.1.1 North America Esoteric Testing Market Overview
    • 10.1.2 North America Esoteric Testing Market Revenue and Forecasts to 2030
    • 10.1.3 North America Esoteric Testing Market Revenue and Forecasts and Analysis - By Type
    • 10.1.4 North America Esoteric Testing Market Revenue and Forecasts and Analysis - By Technology
    • 10.1.5 North America Esoteric Testing Market Revenue and Forecasts and Analysis - By End User
    • 10.1.6 North America Esoteric Testing Market Revenue and Forecasts and Analysis - By Countries
      • 10.1.6.1 United States Esoteric Testing Market
        • 10.1.6.1.1 United States Esoteric Testing Market, by Type
        • 10.1.6.1.2 United States Esoteric Testing Market, by Technology
        • 10.1.6.1.3 United States Esoteric Testing Market, by End User
      • 10.1.6.2 Canada Esoteric Testing Market
        • 10.1.6.2.1 Canada Esoteric Testing Market, by Type
        • 10.1.6.2.2 Canada Esoteric Testing Market, by Technology
        • 10.1.6.2.3 Canada Esoteric Testing Market, by End User
      • 10.1.6.3 Mexico Esoteric Testing Market
        • 10.1.6.3.1 Mexico Esoteric Testing Market, by Type
        • 10.1.6.3.2 Mexico Esoteric Testing Market, by Technology
        • 10.1.6.3.3 Mexico Esoteric Testing Market, by End User
  • 10.2 Europe
    • 10.2.1 Germany
    • 10.2.2 France
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Rest of Europe
  • 10.3 Asia-Pacific
    • 10.3.1 Australia
    • 10.3.2 China
    • 10.3.3 India
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 Rest of Asia-Pacific
  • 10.4 Middle East and Africa
    • 10.4.1 South Africa
    • 10.4.2 Saudi Arabia
    • 10.4.3 U.A.E
    • 10.4.4 Rest of Middle East and Africa
  • 10.5 South and Central America
    • 10.5.1 Brazil
    • 10.5.2 Argentina
    • 10.5.3 Rest of South and Central America

11. Industry Landscape

  • 11.1 Mergers and Acquisitions
  • 11.2 Agreements, Collaborations, Joint Ventures
  • 11.3 New Product Launches
  • 11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

  • 12.1 Heat Map Analysis by Key Players
  • 12.2 Company Positioning and Concentration

13. Esoteric Testing Market - Key Company Profiles

  • 13.1 Georgia Esoteric and Molecular Laboratory LLC
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Laboratory Corp of America Holdings
  • 13.3 Quest Diagnostics Inc
  • 13.4 National Medical Services Inc
  • 13.5 OPKO Health Inc
  • 13.6 ARUP Laboratories Inc
  • 13.7 bioMONTR Labs
  • 13.8 Athena Esoterix LLC
  • 13.9 Stanford Hospital and Clinics
  • 13.10 Foundation Medicine Inc

14. Appendix

  • 14.1 Glossary
  • 14.2 About The Insight Partners
  • 14.3 Market Intelligence Cloud